Johnson Investment Counsel’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-30,914
Closed -$381K 595
2020
Q2
$381K Buy
30,914
+1,222
+4% +$15.1K 0.01% 431
2020
Q1
$267K Sell
29,692
-519
-2% -$4.67K 0.01% 473
2019
Q4
$296K Sell
30,211
-11,996
-28% -$118K 0.01% 509
2019
Q3
$290K Buy
+42,207
New +$290K 0.01% 507
2019
Q2
Sell
-12,056
Closed -$189K 624
2019
Q1
$189K Sell
12,056
-13
-0.1% -$204 ﹤0.01% 577
2018
Q4
$186K Sell
12,069
-545
-4% -$8.4K ﹤0.01% 575
2018
Q3
$271K Buy
12,614
+150
+1% +$3.22K 0.01% 538
2018
Q2
$303K Sell
12,464
-46
-0.4% -$1.12K 0.01% 519
2018
Q1
$213K Sell
12,510
-1,950
-13% -$33.2K 0.01% 576
2017
Q4
$274K Buy
14,460
+158
+1% +$2.99K 0.01% 534
2017
Q3
$251K Sell
14,302
-2,994
-17% -$52.5K 0.01% 543
2017
Q2
$574K Sell
17,296
-551
-3% -$18.3K 0.02% 375
2017
Q1
$572K Buy
17,847
+2,907
+19% +$93.2K 0.02% 358
2016
Q4
$541K Buy
14,940
+4,119
+38% +$149K 0.02% 351
2016
Q3
$497K Sell
10,821
-266
-2% -$12.2K 0.02% 346
2016
Q2
$556K Buy
11,087
+441
+4% +$22.1K 0.02% 321
2016
Q1
$569K Sell
10,646
-917
-8% -$49K 0.02% 310
2015
Q4
$758K Sell
11,563
-676
-6% -$44.3K 0.03% 256
2015
Q3
$691K Sell
12,239
-2,457
-17% -$139K 0.03% 262
2015
Q2
$868K Sell
14,696
-360
-2% -$21.3K 0.03% 233
2015
Q1
$937K Sell
15,056
-339
-2% -$21.1K 0.03% 228
2014
Q4
$885K Sell
15,395
-7,425
-33% -$427K 0.03% 234
2014
Q3
$1.23M Buy
22,820
+2,656
+13% +$143K 0.04% 192
2014
Q2
$1.06M Buy
20,164
+1,542
+8% +$80.8K 0.04% 188
2014
Q1
$983K Sell
18,622
-692
-4% -$36.5K 0.04% 194
2013
Q4
$774K Buy
19,314
+26
+0.1% +$1.04K 0.03% 222
2013
Q3
$728K Sell
19,288
-3,812
-17% -$144K 0.03% 212
2013
Q2
$905K Buy
+23,100
New +$905K 0.04% 178